Eli Lilly and Company (LLY) — what is it worth?
$1,214.70 · $1.1T market cap · Drug Manufacturers - General
Scored from reported financial statements. Data as of 2026-08-12.
Moat
85
Durability of advantage
Management
84
Returns and capital use
Margin of safety
37
Price against value
Buy price
$447.00
Consensus of three methods
Margin of safety price
$447.00
Intrinsic value less 50%
10-CAP price
$251.35
Ten times owner earnings
Payback time price
$396.77
Eight years of free cash flow
Key figures
| Price | $1,214.70 |
| Market cap | $1.1T |
| P/E ratio | 40.8x |
| Return on invested capital | 30.2% |
| Gross margin | 83.8% |
| Debt to equity | 1.60x |
| Free cash flow yield | 0.9% |
| Growth rate used | 15.0% |
| Growth rate measured | 22.0% |
| Exit multiple assumed | 30.0x |
How it compares
Get the weekly implied growth report
One company a week, and the growth rate its price already assumes.
Subscribe free
Run your own assumptions
Every number above is built on assumptions that can be changed. In Moatly you can move the growth rate, the exit multiple and the margin of safety and watch every figure recalculate, so you are testing your own view of Eli Lilly and Company rather than accepting ours.
Get Moatly free on iOS
Not investment advice. Estimates only, built on stated assumptions that could be wrong. Figures are drawn from reported financial statements and were current as of the date shown. Do your own research.